Navigation Links
Cambrex Reports Second Quarter of 2011 Results
Date:8/2/2011

m Continuing Operations

$

4,7577.0%$

3,6666.4%Income  from Discontinued Operations, Net of Tax-1,105Net Income

$

4,7577.0%$

4,7718.3%Basic Earnings per Share of Common Stock:   Income from Continuing Operations

$

0.16$

0.12   Income from Discontinued Operations, Net of Tax

$

-$

0.04   Net Income

$

0.16$

0.16Diluted Earnings per Share of Common Stock:   Income from Continuing Operations

$

0.16$

0.12   Income from Discontinued Operations, Net of Tax

$

-$

0.04   Net Income

$

0.16$

0.16Weighted Average Shares OutstandingBasic29,41929,333Diluted29,49329,404CAMBREX CORPORATIONStatements of Profit and LossFor the Six Months Ended June 30, 2011 and 2010(in thousands)20112010% of% ofAmountSalesAmountSalesGross Sales

$

129,138$

113,558Commissions, Allowances and Rebates814712Net Sales128,324112,846Other6431,464Net Revenues128,967114,310Cost of Goods Sold92,45571.6%81,88472.1%Gross Profit36,51228.3%32,42628.6%Operating ExpensesSelling, General and Administrative Expenses18,27914.1%16,98015.0%Research and Development Expenses5,6324.4%4,8264.2%Total Operating Expenses23,91118.5%21,80619.2%Operating Profit12,6019.8%10,6209.4%Other Expenses/(Income):Interest Expense, net1,1782,369Other (Income)/Expenses, net(285)17Equity in Losses of Partially-Owned Affiliate667-Income Before Income Taxes11,0418.5%8,2347.3%Provision for Income Taxes3,4292,885Income from Continuing Operations

$

7,6125.9%$

5,3494.7%(Loss)/Income  from Discontinued Operations, Net of Tax(146)1,105Net Income

$

7,4665.8%$

6,4545.7%Basic Earnings/(Loss) per Share of Common Stock:   Income from Continuing Operations

$.26$.18   (Loss)/Income from Discontinued Operations, Net of Tax

$

  (0.01)$.04   Net Income

<
'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cambrex Reports Third Quarter 2010 Results
2. Cambrex Reports Fourth Quarter and Full Year 2009 Results
3. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
4. Cambrex Reports First Quarter 2009 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports Third Quarter 2008 Results
7. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
8. Gen-Probe Reports Financial Results for the Second Quarter of 2011
9. Neurocrine Biosciences Reports Second Quarter 2011 Results
10. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... and SHANGHAI , ... privately-held biopharmaceutical company developing next-generation antibiotics, today announced ... clinical study for its lead drug candidate MRX-I. ... treat drug-resistant bacteria such as MRSA and VRE, ... better tolerated therapeutic option than currently available oxazolidinone ...
(Date:8/31/2015)... Aug. 31, 2015 LabStyle Innovations Corp. ... Solution, today announced it recently closed a round ... be used to support the global rollout and ... mobile, cloud-based, diabetes management solution that includes novel ... blood glucose monitoring device, and for working capital ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... ... (PGIs), as a high priority in the drug development approval process. Thus, innovator ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option ... the first commercially available new FDA approved system in the last 14 years, and ... the high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of ...
Breaking Biology Technology:MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3
... Sept. 17 Synvista,Therapeutics, Inc. (Amex: SYI ) ... to the Company,s Web site http://www.synvista.com . The,text ... team at Synvista Therapeutics has made tremendous progress in ... and to redefine,the treatment of cardiovascular disease in diabetics ...
... Sigma-Aldrich Corporation,(Nasdaq: SIAL ) will be presenting ... September 24th at 8:30 AM ET at the Grand ... live audio broadcast over the,Internet available at http://ir.sigmaaldrich.com ... file. For the webcast on, http://ir.sigmaaldrich.com users will ...
... Alfacell Corporation,(Nasdaq: ACEL ) announced today ... of Oppenheimer & Co. as a financial advisor ... alternatives to enhance,shareholder value, including a possible sale ... not be limited to, strategic partnership,transactions., "Alfacell ...
Cached Biology Technology:Synvista Therapeutics Posts Letter to Stockholders on Web Site 2Synvista Therapeutics Posts Letter to Stockholders on Web Site 3Synvista Therapeutics Posts Letter to Stockholders on Web Site 4Synvista Therapeutics Posts Letter to Stockholders on Web Site 5Synvista Therapeutics Posts Letter to Stockholders on Web Site 6Alfacell Hires Advisors to Advance Strategic Alternatives 2Alfacell Hires Advisors to Advance Strategic Alternatives 3
(Date:8/12/2015)... 2015  New research unveiled at Black Hat ... to steal users, fingerprints. Information released today by ... scanners on mobile devices, making the security of ... on mobile devices, HYPR Corp. recently released a ... systems with strong cryptographic security. More information on ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015  Today, ... will visit Crossmatch ™ to learn firsthand ... and protect data. Crossmatch is a world leader ... technologies and expertise are helping federal agencies and ... and security.   "The vast majority ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... wheat ( Triticum aestivum ) is one of the "big ... consumed by people. Fully 35% of the world,s 7 billion ... international team of scientists, including a group from Cold Spring ... its full genome. The study reveals the evolution ...
... a surprise to hear that most adult entertainment club workers ... bartenders, waitresses and hostesses don,t have great medical benefits. ... repeated unwanted sexual advances and behavior. Add in the prevalence ... a perfect storm for unchecked health risks. To ...
... unique aroma signature of the durian revered as the ... the world,s foulest smelling food has uncovered several new ... ACS, Journal of Agricultural and Food Chemistry . ... food shops in the United States and elsewhere, has a ...
Cached Biology News:Bread wheat's large and complex genome is revealed 2Bread wheat's large and complex genome is revealed 3Rhode Island Hospital: Adult entertainment workers likely to benefit from health care intervention 2
Human Cell Line Slides...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA Detection ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Ideally suited for resolving DNA and RNA 10-1000 bases especially PCR products ranging from 100-1000 bp. Gelling temp. (4%) 27C Melting temperature 65C. EEO: 0.10 Rnase/Dnase: none detected...
Biology Products: